[1]
“Sulindac metabolites inhibit epidermal growth factor receptor activation and expression”, JOC, vol. 4, no. 1, Oct. 2005, Accessed: Dec. 06, 2025. [Online]. Available: https://carcinogenesis.com/index.php/JOC/article/view/262